All Sauce from Weekly Sauce:

The official in charge of federal food and drug safety inspections will retire May 14. Michael Rogers, associate commissioner for inspections and investigations at the U.S. Food and Drug Administration (FDA), announced his decision Monday in an email to colleagues. “I have decided to retire. It was my decision, but it was time after 34…  read on >  read on >

The use of nicotine pouches nearly doubled among U.S. high school students between 2023 and 2024, a new study says. These pouches, inserted between the gum and lip, provide teenagers an opportunity to use nicotine in a discreet, easily concealed way, researchers said. About 5.4% of teens said they used nicotine pouches in 2024, compared…  read on >  read on >

Conversion therapy might harm a young person’s long-term heart health, a new study says. Young adults assigned male at birth were nearly three times as likely to be diagnosed with high blood pressure if they’d been exposed to conversion therapy, a discredited practice that attempts to alter a person’s sexual orientation or gender identity, researchers…  read on >  read on >

Stress can make it even worse for people to deal with chronic obstructive pulmonary disease, or COPD, a new study says. High levels of perceived stress are associated with a quadrupled risk of moderate or severe COPD flare-ups (excerbations), researchers reported recently in the Journal of the COPD Foundation. “There is increased evidence that psychosocial…  read on >  read on >

The shingles vaccine has benefits that stretch beyond protecting older adults from the painful skin condition, a new study says. Folks who get the shingles jab have a 23% lower risk of health problems like stroke, heart failure and heart disease, researchers reported May 6 in the European Heart Journal. This protective effect lasts for…  read on >  read on >

The head of the U.S. Food and Drug Administration (FDA) reiterated Tuesday that the agency is applying a more skeptical approach to this year’s round of COVID-19 vaccine boosters. Companies applying for approval of COVID boosters are being encouraged to use “gold standard science,” including full-fledged clinical trials involving healthy people, FDA Commissioner Dr. Marty…  read on >  read on >